Similar articles

• Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.

  Noorbala AA, Akhondzadeh S. Noorbala AA, et al. Arch Iran Med. 2006 Oct;9(4):374-80. Arch Iran Med. 2006. PMID: 17061613 Review.
• Motor cortex modulation and reward in children with attention-deficit/hyperactivity disorder.

  Detrick JA, Zink C, Rosch KS, Horn PS, Huddleston DA, Crocetti D, Wu SW, Pedapati EV, Wassermann EM, Mostofsky SH, Gilbert DL. Detrick JA, et al. Brain Commun. 2021 May 4;3(2):fcab093. doi: 10.1093/braincomms/fcab093. eCollection 2021. Brain Commun. 2021. PMID: 34041478 Free PMC article.
• A prospective observational study of attention-deficit hyperactivity disorder in Asia: baseline characteristics of symptom severity and treatment options in a paediatric population.

  Martényi F, Zheng Y, Huang YS, Lee YS, Walton R, Harrison G, Treuer T. Martényi F, et al. East Asian Arch Psychiatry. 2010 Jun;20(2):76-86. East Asian Arch Psychiatry. 2010. PMID: 22351813
• Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].

  Akhondzadeh S, Mohammadi MR, Khademi M. Akhondzadeh S, et al. BMC Psychiatry. 2004 Apr 8;4:9. doi: 10.1186/1471-244X-4-9. BMC Psychiatry. 2004. PMID: 15070418 Free PMC article. Clinical Trial.
• Attention-deficit/hyperactivity disorder: dietary and nutritional treatments.

  Arnold LE, Hurt E, Lofthouse N. Arnold LE, et al. Child Adolesc Psychiatr Clin N Am. 2013 Jul;22(3):381-402, v. doi: 10.1016/j.chc.2013.03.001. Epub 2013 May 17. Child Adolesc Psychiatr Clin N Am. 2013. PMID: 23806311 Review.